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Davidson v, Lloyd Aircraft Services Ltd [1974] 1 WLR 1054 Deistung v. South West Metropolitan Regional Hospital Board [1975] 1 WLR 213 Denning Lord Justice (1954) The Times, 2 July (in Hatcher v. Black, unreported) Denning Lord, in Lim Poh Choo v. Camden & Islington Area Health Authority [1979] 2 All ER 323 (Court of Appeal) Denning Lord, in Whitehouse v. Jordan [1980] Barnes 1979) there has been a slow but progressive increase in knowledge of Behqet's syndrome. A second international conference was held in Japan in 1981 (Inaba 1982 , O'Duffy et al. 1983 ) and a third is planned for 1985 in London at the Royal Society of Medicine. Nevertheless the cause of this syndrome, of its protean manifestations and of the variation in its severity, overall prevalence and that of individual manifestations in different parts of the world remains unknown.
There have not been any new epidemiological studies but reports of patients with the syndrome continue to appear, including those from mainland China, Middle Eastern countries (Saudi Arabia, Iran) and North Africa (Tunisia, Morocco). The familial incidence has been described further, including a report of 20 affected members in four generations of a single family with the suggestion of an autosomal dominant inheritance (Berman et al. 1979) . Involvement of up to three generations of families has been reported from Japan (Aoki & Sugiura 1982) and Saudi Arabia (Madkour & Kudwah 1981) , and of 4.3% of the relatives of patients in Turkey (Dilaen et al. 1982 ). Both affected and unaffected infants have been born to affected mothers, the clinical manifestations in the affected infant resolving in the first six months of life (Fam et al. 1981 , Hurt et al. 1979 .
The strong association with the HLA-B5 (Bw5 I split) antigen has been confirmed by further studies from Japan, Turkey and Italy (Adorno et al. 1979 , Ohno et al. 1982 , Sasazuki et al. 1982 , Yazici et al. 1980a ). HLA-B5 has been shown to be present in 62-87% of patients in studies from these countries (controls 23-43%), the high incidence being predominantly associated with an increase of HLA-Bw51 in Japan and Turkey (patients 60-84%; controls 15-23%). The incidence of HLA-B5 and Bw51 was not significantly above that of controls in the United Kingdom (B5 18%; Bw51 12%) (Yazici et al. 1980a ). It has been suggested that the HLA-B5 antigen is particularly related to ocular involvement (Lehner et al. 1979) and it is well recognized that there is a very high incidence of ocular disease in Japanese and Turkish patients where the incidence of B5(Bw5l) is higher in the general population than in the United Kingdom.
Hypersensitivity to an intradermal needle prick (a positive 'pathergy test') has again been advocated as a useful diagnostic test. From Japan it was shown that by performing 10 needle pricks at different sites in the same patient the frequency of positive results could be increased from 52% to 84% of patients. Thus in individual patients tested with multiple needle pricks some sites gave a positive result and some negative (Suzuki & Mizuno 1982) . From Turkey it has been proposed that the combination of a positive pathergy test, found in 82% of patients, and the possession of the HLA-B5 antigen, present in 84% of patients, is a diagnostic marker. Both these findings were present in 65% of patients and it was suggested that the diagnosis was virtually excluded if both tests were negative (Yazici et al. 1980b ). However, the pathergy test is not useful in British patients in whom it is almost invariably negative, is not associated with the HLA-Bw5l in control subjects, and is not associated with any differences in the other manifestations of the syndrome (Davies et al. 1984 , Yazici et al. 1984a . Although it has been suggested that different clinical manifestations could be associated with different HLA antigens (Lehner et al. 1979) this has not been confirmed in Turkey (Muftuoglu et al. 1981) .
The arthritis of Beh9et's syndrome has been studied further in a prospective survey of 47 Turkish patients followed for a mean of 47 months (Yurdakul et al. 1983 ). Unlike reports from the United Kingdom (Mason & Barnes 1969 , Chamberlain 1977 , they recorded an episodic pattern of arthritis which was oligoarticular affecting up to four joints per patient, two-thirds of attacks being monarticular, a large majority of which (82%) lasted for up to two months only. Again knees were the most commonly affected joints and usually the arthritis was not destructive.
Synovial biopsy confirmed involvement of the superficial zone of the synovium with surface ulceration, paucity of plasma cells and lymphoid follicle formation in only a minority of the specimens, as previously described (Gibson et al. 1981 , Vernon-Roberts et al. 1978 . Rupture of the synovium of the knee into the calf has now been reported (Dawes et al. 1983 ). This is not surprising in the presence of an inflammatory synovitis and effusion of the knee. However, since this may mimic deep venous thrombosis it is especially necessary to confirm the diagnosis by arthrography, and show the normality of the veins by venography, for vasculitis and venous thrombosis may occur in Behqet's syndrome. (Beaufils et al. 1980) .
Recently the continuing prospective study in progress in Istanbul has confirmed that ocular involvement is more common in males, as is arthritis and vasculitis, whilst erythema nodosum is more common in females. Males and those whose disease starts at or before the age of 24 years have more severe disease and a higher incidence of eye involvement than those in whom the disease starts later (Yazici et al. 1984b ).
The search for a possible viral aetiology continues. This possibility was one of the earliest suggestions, by Beh9et himself, but evidence has been conflicting over the years and remains so. Recently Denman et al. (1-979a, 1980 ) demonstrated that approximately half of lymphocyte cultures from Behqet's patients were unable to support the growth of an inoculum of herpes simplex virus type I, suggesting that a virus was already present in those lymphocytes. Also Eglin et al. (1982) showed, by a viral DNA probe technique, that herpes simplex virus type I is present in a significant proportion of patients' peripheral blood mononuclear cells. Conversely, Yamanouchi et al. (1982) were unable to obtain evidence of a viral aetiology in a comprehensive series of experiments, but these were performed on only a small number of patients. As Yamanouchi himself says, 'the numbers of samples tested is still not enough'.
The Japanese continue to investigate the possible aetiological association with exposure to organophosphate and organochlorine pesticides (Ishikawa et al. 1982) which has not received any attention elsewhere.
A wide variety of immunological disturbances continue to be detected, well reviewed by Lehner (1982) and O'Duffy et al. (1983) . Abnormalities in lymphocyte migration, selective loss of T suppressor cell function, the presence of circulating immune complexes, and variations in immunoglobulins and complement activity have been described. However, it remains uncertain whether Behcet's syndrome should be defined as immunologically mediated or whether the abnormalities detected are a secondary effect of the principal, but unknown, aetiological agent in a susceptible individual and not directly pathogenetic.
Unfortunately, studies of treatment have been unrewarding and have not advanced significantly in the last five years. Since the original controlled trial of Transfer Factor with negative results (Denman et al. 1979b) only one further controlled trial has been reported. That was of the use of colchicine, also with negative results with the possible exception that arthralgia seemed to be reduced (Aktulga et al. 1980) . Reports continue to appear of uncontrolled surveys of treatment with various agents, apparently with beneficial effect, including levamisole, cyclophosphamide, chlorambucil, azathioprine, corticosteroids, antilymphocyte globulin, colchicine, dipyridamol, vitamin E and atropine methyl nitrate. This list indicates not only that some workers still apparently find colchicine of value for their patients but also that no single successful treatment has been identified. There is an urgent need for properly controlled trials of treatment in this syndrome with its wide variability of manifestations and prognosis. Of all the treatments advocated, and until the cause is known, it seems that the use of 'immunosuppressive' drugs, with or without corticosteroids, in the more severely affected patients is most likely to be of value. However, trials of treatment can only be performed where there are sufficient numbers of patients available for study such as in the Eastern Mediterranean area or Japan. There are insufficient patients for such studies in the United Kingdom.
Beh9et's syndrome continues to be an enigma.
Although it is referred to as Behqet's disease by many workers, especially in Turkey, North Africa and Japan, the variability in the prevalence and severity of individual clinical manifestations in different parts of the world, and its unknown aetiology, possibly makes its classification as a 'syndrome' more accurate at the present time. Inevitably two major lines of research need to be pursued: the aetiology and the treatment. Of the former it seems more likely that seeking the initiating cause, such as a virus, will prove more rewarding than the identification of an increasing number of immunological disturbances. Of the latter, and until a cause is identified, there have been too many anecdotal reports of treatment and controlled trials are urgently needed.
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The Royal College of General Practitioners and the General Medical Services Committee of the British Medical Association are in the process of producing a record card with an accompanying handbook outlining a plan for a developmental surveillance programme suitable for use in general practice and, hopefully, by others. These plans fit neatly into the proposals put forward by Donald Court in the accompanying paper in this issue (p 863). In preparing such documents two questions immediately come to mind: firstly, is there a need for developmental surveillance; and, secondly, who is to do the work?
It is the natural wish of parents that their children should grow and achieve their maximum potential. The knowledge that many disablingand even lethaldiseases can be prevented led to the introduction of well-baby clinics, initially run mainly by Local Health Authorities. In the 1974 reorganization these were taken over by NHS Area Health Authorities and now District Health Authorities. Over the years more and more general practitioners have also taken to running their own well-baby clinics, sometimes in direct collaboration with the health authority and usually in conjunction with health visitors. Now that all new entrants to general practice have undertaken a period of vocational training, usually including a six-month appointment in paediatrics, even more practices are including the care of well babies as part of the service they offer.
The function of these clinics is threefold. Firstly, there is the examination of all babies at appropriate intervals to see that they are growing normally (height/length, weight, skull circumference and, perhaps, skin thickness) and that such disabilities or potential disabilities as warrant intervention can be identified so that remedial action can be taken as soon as practicable. The most important tests are those directed at identifying congenital dislocation of the hips, squint, hearing loss and, in boys, maldescent or non-descent of the testes. Other tests are directed at identifying any defects in the four major functions: gross and fine motor, coordination and language development.
A number of other tests can also be carried out but, for many, their validity remains to be proven; for example, doubt has recently been shed on the rolling ball tests used to determine visual acuity (Hall et al. 1982) . In other instances, for example, the recognition of either mental handicap or spasticity, does the benefit of telling the parents of our suspicions at the earliest stage outweigh the disadvantage of generating unnecessary anxiety? Perhaps the best time for the doctor (or health visitor) to raise the issue is just before the parents themselves begin to suspect something is amiss.
The second functionand perhaps the major oneis the reassurance of the parents that their baby is developing normally. To achieve this it is necessary to create a relaxed atmosphere. The motheralso father and, even more important, grandmother if she is presentmust be encouraged to express all their worries and fears, rational or irrational. It is only after the doctor and health visitor have found out what is going on in the mother's mind, and answered all queries and doubts, that they can say to her 'Your baby is normal' -often adding 'You are doing very well as a mother'..
The third function is the routine immunization of babies. Opinions differ as to whether this should be done at the same time as developmental surveillance is being carried out. At the meeting on child health surveillance held jointly by the Sections of General Practice and Paediatrics on 15 February 1984, Graham Curtis Jenkins strongly expressed the view that both sessions should be combined, to the advantage of the parents by reducing the frequency of 'Arising from presentation to joint meeting of Sections of General Practice and Paediatrics, 15 February 1984 0 141-0768/84/100819-02/$O1 .00/0
